293 related articles for article (PubMed ID: 18397958)
1. Eotaxin-3 is involved in Churg-Strauss syndrome--a serum marker closely correlating with disease activity.
Polzer K; Karonitsch T; Neumann T; Eger G; Haberler C; Soleiman A; Hellmich B; Csernok E; Distler J; Manger B; Redlich K; Schett G; Zwerina J
Rheumatology (Oxford); 2008 Jun; 47(6):804-8. PubMed ID: 18397958
[TBL] [Abstract][Full Text] [Related]
2. Eotaxin-3 in Churg-Strauss syndrome: a clinical and immunogenetic study.
Zwerina J; Bach C; Martorana D; Jatzwauk M; Hegasy G; Moosig F; Bremer J; Wieczorek S; Moschen A; Tilg H; Neumann T; Spriewald BM; Schett G; Vaglio A
Rheumatology (Oxford); 2011 Oct; 50(10):1823-7. PubMed ID: 21266446
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic pathway of apoptosis in peripheral blood eosinophils of Churg-Strauss syndrome.
Jakiela B; Szczeklik W; Sokolowska B; Mastalerz L; Sanak M; Plutecka H; Szczeklik A
Rheumatology (Oxford); 2009 Oct; 48(10):1202-7. PubMed ID: 19643727
[TBL] [Abstract][Full Text] [Related]
4. Serum eosinophil cationic protein: a marker of disease activity in Churg-Strauss syndrome.
Guilpain P; Auclair JF; Tamby MC; Servettaz A; Mahr A; Weill B; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1107():392-9. PubMed ID: 17804567
[TBL] [Abstract][Full Text] [Related]
5. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic nasal polyps are a rich source of eotaxin, eotaxin-2 and eotaxin-3.
Olze H; Förster U; Zuberbier T; Morawietz L; Luger EO
Rhinology; 2006 Jun; 44(2):145-50. PubMed ID: 16792175
[TBL] [Abstract][Full Text] [Related]
8. Serum biomarkers are similar in Churg-Strauss syndrome and hypereosinophilic syndrome.
Khoury P; Zagallo P; Talar-Williams C; Santos CS; Dinerman E; Holland NC; Klion AD
Allergy; 2012 Sep; 67(9):1149-56. PubMed ID: 22775568
[TBL] [Abstract][Full Text] [Related]
9. Initial cutaneous manifestations consistent with mononeuropathy multiplex in Churg-Strauss syndrome.
Kawakami T; Soma Y; Kawasaki K; Kawase A; Mizoguchi M
Arch Dermatol; 2005 Jul; 141(7):873-8. PubMed ID: 16027304
[TBL] [Abstract][Full Text] [Related]
10. Increased production of IL-5 and dominant Th2-type response in airways of Churg-Strauss syndrome patients.
Jakiela B; Szczeklik W; Plutecka H; Sokolowska B; Mastalerz L; Sanak M; Bazan-Socha S; Szczeklik A; Musial J
Rheumatology (Oxford); 2012 Oct; 51(10):1887-93. PubMed ID: 22772323
[TBL] [Abstract][Full Text] [Related]
11. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.
Schmitt WH; Csernok E; Kobayashi S; Klinkenborg A; Reinhold-Keller E; Gross WL
Arthritis Rheum; 1998 Mar; 41(3):445-52. PubMed ID: 9506572
[TBL] [Abstract][Full Text] [Related]
12. [Churg-Strauss syndrome].
Garini G; Corradi D; Vaglio A; Buzio C
Recenti Prog Med; 2003 Dec; 94(12):573-81. PubMed ID: 14974155
[TBL] [Abstract][Full Text] [Related]
13. [Detection of eotaxin and its clinical diagnosis value in patients with bronchial asthma].
Liu ZJ; Ren YL; Lin JY; Ni AP
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):298-301. PubMed ID: 15266834
[TBL] [Abstract][Full Text] [Related]
14. Increased serum high mobility group box-1 level in Churg-Strauss syndrome.
Taira T; Matsuyama W; Mitsuyama H; Kawahara KI; Higashimoto I; Maruyama I; Osame M; Arimura K
Clin Exp Immunol; 2007 May; 148(2):241-7. PubMed ID: 17437420
[TBL] [Abstract][Full Text] [Related]
15. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
[TBL] [Abstract][Full Text] [Related]
16. Proinflammatory cytokines and autoimmunity in Churg-Strauss syndrome.
Hellmich B; Csernok E; Gross WL
Ann N Y Acad Sci; 2005 Jun; 1051():121-31. PubMed ID: 16126951
[TBL] [Abstract][Full Text] [Related]
17. Serum thymus and activation-regulated chemokine, macrophage-derived chemokine and eotaxin as markers of severity of atopic dermatitis.
Jahnz-Rozyk K; Targowski T; Paluchowska E; Owczarek W; Kucharczyk A
Allergy; 2005 May; 60(5):685-8. PubMed ID: 15813816
[TBL] [Abstract][Full Text] [Related]
18. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease.
Falcone C; Minoretti P; D'Angelo A; Buzzi MP; Coen E; Emanuele E; Aldeghi A; Olivieri V; Geroldi D
Eur J Clin Invest; 2006 Apr; 36(4):211-7. PubMed ID: 16620281
[TBL] [Abstract][Full Text] [Related]
19. Differences in regulatory T cells between Churg-Strauss syndrome and chronic eosinophilic pneumonia with asthma.
Tsurikisawa N; Saito H; Tsuburai T; Oshikata C; Ono E; Mitomi H; Akiyama K
J Allergy Clin Immunol; 2008 Sep; 122(3):610-6. PubMed ID: 18586318
[TBL] [Abstract][Full Text] [Related]
20. Mepolizumab as a steroid-sparing treatment option in patients with Churg-Strauss syndrome.
Kim S; Marigowda G; Oren E; Israel E; Wechsler ME
J Allergy Clin Immunol; 2010 Jun; 125(6):1336-43. PubMed ID: 20513524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
